Artificial Intelligence in Oncology Drug Discovery and Development
There exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic bur...
Gorde:
| Beste egile batzuk: | , |
|---|---|
| Formatua: | Liburu kapitulua |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | Get Fullteks DOAB: description of the publication |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
| Gaia: | There exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic burden of cancer increases, the current paradigm in drug development is unsustainable. In this book, we discuss the development of techniques in machine learning for improving the efficiency of oncology drug development and delivering cost-effective precision treatment. We consider how to structure data for drug repurposing and target identification, how to improve clinical trials and how patients may view artificial intelligence. |
|---|---|
| ISBN: | /doi.org/10.5772/intechopen.88376 9781789858983 |
| Sartu: | Open Access |